The Readout Loud
Episode 201: Doing biotech in Ukraine, drug pricing déjà vu, & Covid surges overseas
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
How should pharma treat Russia? Why can't Congress pass a drug pricing bill? And what does wastewater portend for the pandemic?
First, we discuss the drug industry's response to Russia's invasion of Ukraine, and STAT reporter Isabella Cueto joins us to explain how the war has affected the quietly vibrant Ukrainian biotech industry. Then, STAT Washington correspondent Nicholas Florko calls in to review Congress' years of failure to pass laws on drug pricing and examine whether bipartisan support can ever result in actual legislation. We also run through the latest news in the life sciences, including Ashish Jha's new job, global Covid-19 surges, and a long-delayed manuscript from Biogen.